National Institute of Allergy & Infectious Diseases (NIAID)
31 Center Drive MSC 2520
Building 31, Room 7A-50
Bethesda
Maryland
20892-2520
United States
Tel: 301-496-5717
Website: http://www.niaid.nih.gov/
307 articles about National Institute of Allergy & Infectious Diseases (NIAID)
-
Cytheris SA Announces Initiation of National Institute of Allergy And Infectious Diseases (NIAID)/National Institutes of Health (NIH)-Sponsored Phase I/IIa Clinical Trial of Interleukin-7 (IL-7)
10/14/2009
-
National Institute of Allergy And Infectious Diseases (NIAID) to Fund Development of Emergent BioSolutions' Advanced Anthrax Vaccine Candidate
9/30/2009
-
GenVec Inc. Receives Fourth-Year Funding From National Institute of Allergy And Infectious Diseases (NIAID) For HIV Vaccine Contract
9/24/2009
-
One Swine Flu Shot Enough for Older Kids, National Institute of Allergy And Infectious Diseases (NIAID) Researchers Say
9/22/2009
-
National Institute of Allergy And Infectious Diseases (NIAID) Awards Cleveland Biolabs Inc. Additional Grant for Protectan CBLB502 Research in Mitigation of Radiation Damage
9/22/2009
-
Rib-X Pharmaceuticals, Inc. Receives Award from National Institute of Allergy And Infectious Diseases (NIAID) to Develop Antibiotic Treatment for Gonorrhea
9/15/2009
-
Rib-X Pharmaceuticals, Inc. Receives Award from National Institute of Allergy And Infectious Diseases (NIAID) to Develop Antibiotic Treatment for Gonorrhea
9/14/2009
-
Statement by Dr. Anthony Fauci, Director, National Institute of Allergy And Infectious Diseases (NIAID), National Institutes of Health (NIH), Regarding Early Results from Clinical Trials of 2009 H1N1 Influenza Vaccines in Healthy Adults
9/11/2009
-
So Far, No "Red Flags" Seen In H1N1 Vaccine, National Institute of Allergy And Infectious Diseases (NIAID) Announce
8/24/2009
-
Nanotherapeutics Awarded $30.9 Million National Institute of Allergy And Infectious Diseases (NIAID) Contract to Develop Inhaled Antiviral for Prophylaxis and Treatment of Smallpox
8/24/2009
-
The National Institute of Allergy And Infectious Diseases (NIAID)-Supported Pathogen Functional Genomics Resource Center at the J. Craig Venter Institute Offers New Affymetrix (Santa Clara, California) Array for Faster Identification of E. Coli and Shigel
8/5/2009
-
Genes Key To Staph Disease Severity, Drug Resistance Found Hitchhiking Together, National Institute of Allergy And Infectious Diseases (NIAID), University of Tubingen, And University of Medicine and Dentistry of New Jersey Study
8/3/2009
-
Scientists Discover New Genetic Immune Disorder In Children, National Institute of Allergy And Infectious Diseases (NIAID) Study
6/4/2009
-
National Institutes of Health (NIH)'s National Institute of Allergy And Infectious Diseases (NIAID) Initiates Study of Aeolus Pharmaceutical Drug as a Countermeasure for Radiation Exposure
6/3/2009
-
J. Craig Venter Institute Awarded $43 Million, Five Year Contract From National Institute of Allergy And Infectious Diseases (NIAID)
5/29/2009
-
SRI International to Screen Drugs That Fight 2009 H1N1 Influenza A
5/13/2009
-
Napo Pharmaceuticals, Inc. Initiates Preclinical Development of a Novel CFTR Inhibitor Using Preclinical Resources Offered by the National Institute of Allergy And Infectious Diseases (NIAID)
5/5/2009
-
Bacilligen, Inc. To Develop Influenza Vaccine
4/28/2009
-
New Understanding Of Dengue Virus Points Way To Possible Therapies For Dengue Fever, Duke University Medical Center Study Funded By National Institute of Allergy And Infectious Diseases (NIAID)
4/23/2009
-
Alcohol Flush Signals Increased Cancer Risk Among East Asians, National Institute of Allergy And Infectious Diseases (NIAID) Study
3/24/2009